Advances in oral peptide therapeutics
DJ Drucker - Nature reviews Drug discovery, 2020 - nature.com
Protein and peptide therapeutics require parenteral administration, which can be a deterrent
to medication adherence. For this reason, there have been extensive efforts to develop …
to medication adherence. For this reason, there have been extensive efforts to develop …
Cell-penetrating peptides in diagnosis and treatment of human diseases: from preclinical research to clinical application
J Xie, Y Bi, H Zhang, S Dong, L Teng, RJ Lee… - Frontiers in …, 2020 - frontiersin.org
Cell-penetrating peptides (CPPs) are short peptides (fewer than 30 amino acids) that have
been predominantly used in basic and preclinical research during the last 30 years. Since …
been predominantly used in basic and preclinical research during the last 30 years. Since …
Progress in research of chitosan chemical modification technologies and their applications
Q Chen, Y Qi, Y Jiang, W Quan, H Luo, K Wu, S Li… - Marine Drugs, 2022 - mdpi.com
Chitosan, which is derived from chitin, is the only known natural alkaline cationic polymer.
Chitosan is a biological material that can significantly improve the living standard of the …
Chitosan is a biological material that can significantly improve the living standard of the …
An overview of in vitro, ex vivo and in vivo models for studying the transport of drugs across intestinal barriers
Oral administration is the most commonly used route for drug delivery owing to its cost-
effectiveness, ease of administration, and high patient compliance. However, the absorption …
effectiveness, ease of administration, and high patient compliance. However, the absorption …
[HTML][HTML] Strategic approaches for colon targeted drug delivery: an overview of recent advancements
SH Lee, R Bajracharya, JY Min, JW Han, BJ Park… - Pharmaceutics, 2020 - mdpi.com
Colon targeted drug delivery systems have gained a great deal of attention as potential
carriers for the local treatment of colonic diseases with reduced systemic side effects and …
carriers for the local treatment of colonic diseases with reduced systemic side effects and …
[HTML][HTML] The influence of the gut microbiota on the bioavailability of oral drugs
X Zhang, Y Han, W Huang, M Jin, Z Gao - Acta Pharmaceutica Sinica B, 2021 - Elsevier
Due to its safety, convenience, low cost and good compliance, oral administration attracts
lots of attention. However, the efficacy of many oral drugs is limited to their unsatisfactory …
lots of attention. However, the efficacy of many oral drugs is limited to their unsatisfactory …
Emerging theranostic nanomaterials in diabetes and its complications
Y Liu, S Zeng, W Ji, H Yao, L Lin, H Cui… - Advanced …, 2022 - Wiley Online Library
Diabetes mellitus (DM) refers to a group of metabolic disorders that are characterized by
hyperglycemia. Oral subcutaneously administered antidiabetic drugs such as insulin …
hyperglycemia. Oral subcutaneously administered antidiabetic drugs such as insulin …
Oral insulin delivery platforms: strategies to address the biological barriers
Diabetes mellitus is a lifelong metabolic disease that requires frequent subcutaneous
injections of insulin. However, this method of administration can be associated with patient …
injections of insulin. However, this method of administration can be associated with patient …
Cell-penetrating peptide: a means of breaking through the physiological barriers of different tissues and organs
J Xu, AR Khan, M Fu, R Wang, J Ji, G Zhai - Journal of Controlled Release, 2019 - Elsevier
The selective infiltration of cell membranes and tissue barriers often blocks the entry of most
active molecules. This natural defense mechanism prevents the invasion of exogenous …
active molecules. This natural defense mechanism prevents the invasion of exogenous …
Micromotor based mini-tablet for oral delivery of insulin
K Liu, Q Liu, J Yang, C Xie, S Wang, F Tong, J Gao… - ACS …, 2022 - ACS Publications
Diabetes is a metabolic disorder characterized by hyperglycemia due to defective insulin
secretion or its biological dysfunction. However, frequent subcutaneous injection of insulin …
secretion or its biological dysfunction. However, frequent subcutaneous injection of insulin …